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 Abstract 
 
An in vitro model of intracerebral hemorrhage was established to examine the 
protective versus cytotoxic roles of microglia in the context of mild versus severe 
injury.  Co-cultures of microglia, astrocytes, and granule neurons were prepared 
from the cerebellar cortex of neonatal rats, and grown in standard medium 
containing fetal bovine serum or, in some cases, a serum-free chemically defined 
medium.  To mimic hemorrhagic stroke, co-cultures grown for 7-8 days in vitro 
were challenged with two different concentrations of the toxic blood product 
hemin, corresponding to a mild versus a severe brain bleed. Immunocyto-
chemical, real-time RT-PCR, iron deposition, and cell survival assays were 
performed to assess the effects of hemin, with emphasis on the functional effector 
states of microglia.  In cultures grown in serum-containing medium, the lower 
concentration of hemin (20 µM) induced significant expression of the protective 
enzyme, heme oxygenase 1 (HO-1).  Consistent with this, iron deposition was 
localized to the microglia in the cultures.  Only a modest induction of the 
inflammatory molecule TNF-α, and no significant cell death was observed 24 hrs 
after hemin addition.  In contrast, the higher concentration of hemin (100 µM) 
induced greater expression of HO-1, and iron deposition was detected in all three 
cell types in the cultures.  Moreover, significant and robust induction of the 
inflammatory molecules TNF-α, COX-2, iNOS, and significant neuronal death 
were observed.  These results suggest that microglia are protective and serve to 
effectively catabolize hemin when exposed to 20 µM hemin.  However, 
increasing the hemin concentration to 100 µM appears to exceed the capacity of 
the microglia to effectively catabolize the hemin load, resulting in an 
inflammatory and cytotoxic environment.  Serum proteins, in particular albumin 
and hemopexin, can bind blood products such as hemin, and slowly release them 
to be processed by microglia after a brain bleed.  To test the possible protective 
effect of albumin, co-cultures grown in a chemically defined medium lacking 
serum were exposed to hemin as described above, with or without co-addition of 
an equivalent amount of albumin.  In these cultures, significant neuronal death 
was observed in response to 20 µM hemin, with essentially total cell death in 
response to 100 µM hemin.  Addition of albumin to the cultures significantly 
decreased the amount of neuronal death in response to both concentrations of 
hemin.  These data suggest that addition of agents that bind toxic blood products 
may serve as protective agents after hemorrhagic stroke.  In future studies, this in 
vitro model should prove valuable in characterizing the signaling pathways 
underlying distinct functional effector states of microglia, and developing 
strategies to preserve the protective phenotype.  
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 Executive Summary 
 
 Strokes occur when the brain does not get enough blood, leading to 
neuronal death.  There are two primary types of strokes, called ischemic and 
hemorrhagic.  A hemorrhagic stroke occurs after a blood vessel bursts, releasing 
blood contents directly into the brain tissue.  Although hemorrhagic strokes are 
less common than ischemic strokes, they cause greater impairment and more 
deaths.  The scarcity of treatments available for patients who suffer brain bleeding 
shows the importance of research that focuses on factors underlying brain 
damage, and what can be done to prevent it.  My project uses a cell culture model 
to mimic hemorrhagic stroke.  We take tissue from the brains of rats and 
experimentally grow neurons, astrocytes and microglia to study the roles of 
microglia in response to injury that mimics brain bleeding.  Microglia can be 
protective by internalizing the toxic blood products before they have a chance to 
do damage, but microglia can also be overwhelmed by an excessive amount of 
blood and become toxic, increasing the amount of damage.  Currently, therapies 
aimed at inhibiting the functions of microglia are being studied to treat strokes 
and other brain injuries.  However, we believe that it is important to recognize the 
differences between injuries that preserve the protective functions of microglia 
versus injuries that result in conversion of microglia to states that make injuries 
worse, called cytotoxic. One would not want to use a microglia inhibitor under 
injury conditions where microglia are serving a protective role. 
 To better understand the different states that microglia assume in response 
to a brain bleed, we used low and high concentrations of the potentially toxic 
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 blood product hemin.  We reasoned that the low concentration of hemin would be 
effectively cleared by the microglia without causing cell damage, whereas the 
higher concentration of hemin would lead to microglial overload, and generate 
production of toxic molecules causing death of neurons in the cultures. When 
hemin is introduced to the environment, microglia and possibly other cells 
produce the protective enzyme, called heme oxygenase-1 (HO-1), which breaks 
down the hemin into carbon monoxide, biliverdin, and free iron. The amount of 
HO-1 mRNA generated was quantified using RT-PCR, which is a technique that 
measures RNA expression.  Our results showed that more HO-1 was induced as 
the concentration and duration of exposure to hemin was increased.  Through 
staining with hemin-specific antibodies, it was also determined that the HO-1 
generation was primarily localized in the microglia.  Additionally, we expected 
there to be iron deposited in the microglia since iron is a product released when 
hemin is broken down.  We performed an iron stain and found that, when the cells 
are challenged with a low concentration of hemin, the iron is localized within the 
microglia.   However, when they are challenged with a high concentration of 
hemin, the iron is taken up by all the cell types indicating that the microglia alone, 
are unable to process the large hemin load.  Similarly, there is little or no neuronal 
death in response to the low concentration of hemin, but there is substantial 
neuronal death in response to the high concentration of hemin, as assessed using 
various cell viability assays.  Moreover, only the higher concentration of hemin 
led to the production of several inflammatory molecules, which are markers of 
cell toxicity.  These results suggest that microglia are protective and effectively 
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 break down hemin when exposed to the low concentration.  However, increasing 
the hemin concentration appears to exceed the capacity of the microglia to 
effectively catabolize the hemin load, resulting in an inflammatory and cytotoxic 
environment.  Using a modification of our culture model, we also observed that 
addition of a serum protein, albumin, protected the neurons from dying after 
exposure to hemin. These results suggest that added albumin binds the toxic 
hemin and serves to protect the neurons.  In future studies, our model should 
prove valuable in developing strategies to protect the brain against toxic blood 
products as occurs after a hemorrhagic stroke.  
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 Introduction  
 
 Ischemic strokes result from the formation of clots in blood vessels, which 
prevent delivery of oxygen and nutrients to brain tissue. This type of stroke in the 
United States accounts for the majority of all stroke types. Hemorrhagic strokes 
result when vasculature weakens and rupture releasing blood directly into the 
brain parenchyma in cases of intracerebral hemorrhage. Although hemorrhagic 
strokes make up only 10-15% of all stroke types, they are much more devastating 
in terms of mortality and morbidity compared to ischemic stroke. For example, 
about 35-52% of people who have hemorrhagic strokes die within 30 days (Taylor 
and Sensing, 2013).  Currently, there is a lack of effective treatments for patients 
who suffer intracerebral hemorrhages, demonstrating the importance of research 
aimed at understanding the pathogenesis of neuronal damage following 
hemorrhagic stroke, and possible strategies to prevent or reduce the extent of the 
injury.  
 We are using co-cultures of neurons, astrocytes and microglia as a simple 
and convenient model to assess the functional effector states of microglia in 
response to different types of injury. The earliest studies on microglia defined two 
functional states; resting, which coincided with a ramified morphology, and 
active, which correlated to an amoeboid morphology and expression of a host of 
gene products that served to mobilize the microglia to the site of injury and 
promote phagocytosis (Ravish et al. 1999; Streit et al. 2002; Hanisch and 
Kettenmann 2007; Ransohoff and Perry 2009; Salter and Beggs 2014). Studies 
done more recently, have shown that microglia assume a range of phenotypes 
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 depending on the duration and extent of injury. Resting microglia exhibit a highly 
ramified phenotype with numerous processes and a small compact soma. These 
cells are not stagnant but, instead, are constantly surveying the local environment 
for minor damage. When exposed to mild or moderate injuries, they transition to a 
less ramified, phagocytic phenotype in which they are protective and function to 
remove substances from the environment to limit inflammation and restore 
homeostasis. However, with more severe injuries, microglia may lose their 
phagocytic functions and transition to rounded, pro-inflammatory phenotypes that 
actually enhance tissue damage (Hanisch and Kettenmann 2007; Salter and Beggs 
2014). From a clinical prospective, microglia inhibitors are being actively 
investigated in humans for a variety of brain injuries such as ischemic and 
hemorrhagic stroke, multiple sclerosis, neurodegenerative diseases, and numerous 
formed of brain trauma and cerebral edema (Bachstetter et al. 2012; Bachstetter et 
al. 2013; Sloka et al. 2013; Neher et al. 2013; Xie et al. 2014; Chen et al. 2014; 
Huang et al. 2014; Kabati et al. 2014). However, we believe it is important to 
distinguish between the different phenotypes of microglia because treatment to 
inhibit microglia functions may be useful only when they have converted to the 
cytotoxic, inflammatory phenotype. If inhibited while assuming the other states, 
the protective functions of the microglia may be lost, thereby preventing the cells 
from containing the damage and returning the environment to homeostasis.  
  In our laboratory, we use different concentrations of the toxic blood 
product hemin (20 µM and 100 µM) to model a mild to moderate versus a severe 
hemorrhagic stroke. When a blood vessel ruptures in the brain, the blood cells that 
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 surround brain tissue lyse releasing hemoglobin and other toxic blood products. 
Hemoglobin then breaks down into heme (or hemin), a product that may be toxic. 
Microglia take up these blood products and catabolize them. To protect against 
oxidative injury, there is an induction in the enzyme heme oxygenase-1 (HO-1) 
within microglia and perhaps other cell types, which catabolize heme into carbon 
monoxide, biliverdin, and free iron (Robinson et al., 2009; Dang et al., 2011). Our 
working hypothesis is that microglia transition to distinct functional effector states 
in response to different hemin loads, corresponding to mild to moderate versus 
severe injury. When the hemin load is mild or moderate, we predict that microglia 
are able to effectively internalize the hemin, catabolize it without demonstrating a 
robust inflammatory response, and return the system to homeostasis, avoiding 
neuronal damage or death. When the hemin load becomes excessive, we predict 
the microglia are overwhelmed and are unable to effectively manage the removal 
and catabolism of hemin from the environment. In such cases, neuronal death and 
expression of inflammatory markers are expected. To test these hypotheses, after 
our cultures are exposed to low and high concentrations of hemin, alterations in 
microglia effector states were examined using immunohistochemistry techniques, 
real-time RT-PCR assays, an iron deposition assay, a phagocytosis assay, and 
live-dead assays to assess neuronal survival. 
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 Methods  
Tissue Culture: 
 
 Granule cell-enriched cultures were prepared as described by Vallano et 
al. (1996). However, for this study, the mitotic inhibitor AraC was omitted from 
the growth medium to promote the growth of astrocytes and microglia (Beaman-
Hall et al. 1998). Briefly, the cerebella of 8-day-old Sprague-Dawley rats were 
minced, trypsinized, and triturated to separate cells. The cells were plated at a 
density of 1.25 x 106 cells/ml of medium onto 12-well Corning dishes (for live-
dead assays, and RT-PCR assays) or 24-well Corning dishes containing glass 
coverslips precoated with poly-L-lysine (for immunocytochemistry). They were 
then incubated at 37°C in a humidified atmosphere containing 5% CO2/95% air 
(pH 7.4). Cultures with abundant microglia and astrocytes were grown in basal 
Eagle’s medium with Earle’s salts, enhanced with heat-inactivated fetal bovine 
serum (10%), gentamicin sulfate (100 µg/ml), and L-glutamine (2mM). To ensure 
the lasting survival of cerebellar granule neurons (CGNs), 20mM KCl (25mM 
f.c.) was added to the growth medium (Thangnipon et al. 1983; Kingsbury et al. 
1985; Gallo et al. 1987). At 7-8 days in vitro (DIV), the CGNs mature and 
develop sensitivity to addition of excitotoxic agents (Leahy et al. 1994), and 
hemin experiments were done at this phase of growth. Although the medium was 
not replaced during this time, the addition of 5.5 mM glucose at 6 DIV ensured 
the lasting survival of the cells (Schramm et al. 1990). Phase contrast microscopy 
was utilized in evaluating the viability of the cells regularly.   
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 Excitotoxicity: 
 
 Cell viability was assessed using a lactate dehydrogenase (LDH) assay as 
described by Decker and Lohmann-Matthes (1988). Fluorescent staining 
techniques were also used to visualize live and dead cells using a live/dead kit in 
which calcein was used to stain living cells and PI to stain dead cells (Invitrogen). 
Hemin (20 µM or 100 µM) was added and, at 24 hours, the relative amounts of 
living and dead cells were quantified.  Up to four fields per coverslip comprising 
of at least one hundred cells were photographed. The total number of living and 
dead CGNs, in relation to microglia and astrocytes were also quantified to 
estimate the relative proportions of glia and neurons in the cultures. In one series 
of experiments, kainic acid was used to model ischemic injury and, for 
comparative purposes, I will present some of these data that were done by another 
laboratory member.  
Immunocytochemistry:   
 
 Phase-contrast microscopy and immunocytochemical staining with the 
microglial markers ED1 and Iba1 (estimated as ~11% of cells at 7-8 DIV), and 
the abundant neuronal protein β-tubulin (not shown) were used to observe the 
production of abundant microglia and neurons in culture. Astrocytes were labeled 
using an antibody against GFAP (estimated as ~10% of cells at 7-8 DIV). 
Cultures were fixed with 4% paraformaldehyde 24 hrs after toxicity (7-8 DIV), 
permeabilized with 0.3% Triton X-100 and 4% normal donkey serum in 
phosphate-buffered saline (PBS) was added for 20 min at room temperature. 
Following the manufacturer’s protocol, the following antibodies were added to 
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 the cultures: ED1(1:300) mouse anti-rat monoclonal antibody, Iba1(1:1000) anti-
rabbit polyclonal,  GFAP (1:1000) anti-rabbit polyclonal antibody, iNOS (1:1000) 
anti-rabbit polyclonal were added for 24 hrs at 4°C. Cultures were then washed 3x 
with PBS and incubated in Alexa fluor 488 donkey anti-mouse secondary 
antibody (1:400) or Alexa fluor 488 donkey anti-rabbit (1-400), and Alexa fluor 
594 donkey anti-rabbit (1:400) for 1 hr at room temperature. Before they were 
photographed under a fluorescent microscope, Vectashield Antifade (Vector 
Laboratories) or Vectashield Antifade with PI if ED1 was used to mount 
coverslips. Cells positively labeled with Iba1 in two randomly photographed 
fields per coverslip were counted in 3 different cell culture preparations.  
Phagocytosis assay:  
 
 A phagocytosis assay was performed using 5.5 µm polystyrene beads as 
previously described (Bocchini et al. 1988a, 1988b). Briefly, cultures were 
prepared as above and plated on 12mm glass coverslips at a density of 1.25 x 106 
cells/ml and cultured for 7-8 DIV.  Then, 1.5 µl/ml of 5.5 µm fluorescent 
microspheres were added directly to the cultures and incubated for 1 hr at 370C. 
To remove lingering microspheres, cells were washed three times with PBS 
before being fixed with 4% formalin in PBS. Iba1 or GFAP antibodies were used 
as detailed above to label cells. Four random fields were photographed.  
Iron stain: 
 
 To visualize hemin uptake into cells, iron deposition was examined. After 
hemin exposure for 24 hrs, cultures were washed three times with PBS and then 
incubated with 5% potassium ferrocyanide for 30 minutes. After the removal of 
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 the 5% potassium ferrocyanide, the cultures were exposed to HCl for 30 minutes. 
DAB-NI without H2O2 from the Vector Kit was added for 15 minutes followed by 
DAB-NI with H2O2 for 15 minutes. The cultures were washed with PBS three 
times before four random fields were photographed. 
RT-PCR:  
 
 Real-time quantitative RT-PCR (qRT-PCR) analysis was done to examine 
the induction of mRNAs reflecting the expression of heat shock protein (HO-1 
and inflammatory molecules (TNF-α, COX-2, iNOS) using a Light-cycler 480 
System (Roche Applied Sci) using SYBR Green, a fluorescent double-stranded 
DNA Dye as previously described by our laboratory (Gerber et al. 2010). Samples 
were analyzed in triplicate PCR reactions on a single 384 well plate and the data 
was quantified. Amplification in the absence of template was evaluated to ensure 
lack of signal due to primer dimerization and extension. To verify the presence of 
a single amplicon in each reaction well, end point melt-curve analysis was done. 
The ∆∆CT method (with 18S as an internal reference) was done to analyze the 
data, and a repeated measures ANOVA model using the ∆CT data. Validity of the 
∆∆CT method was confirmed by indicating equivalent efficiencies of 
amplification of the 18S RNA normalization control versus the target mRNAs 
over a range of serial dilutions. The primer sets used are shown in Table 1. 
Statistical analysis: 
 
Values are presented as mean ± standard deviation of the mean. Analysis 
of Variance (ANOVA) and Fisher’s Protected Least Significant Difference 
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 (PLSD) or Tukey/Kramer post hoc test were used to compare the groups 
statistically. A probability of p < 0.05 is considered statistically significant. 
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 Results 
 
Co-cultures of microglia, astrocytes and neurons:  
 Figure 1 is a representative image showing the presence of three primary 
cell types in our co-cultures, which were fixed at 8 DIV.  Numerous rounded 
microglia are shown in green using the microglial marker Iba1. Many fibrous 
astrocytes are shown in red using the astrocyte marker GFAP.  The nuclear stain 
Hoeschst was used to stain the nuclei of all cells in the culture.  The image shows 
several clusters of blue nuclei throughout the culture that are not labeled with 
microglia or astrocytes markers, and corresponding to granule neurons. 
Phagocytic activity of microglia: 
 Past studies have demonstrated that both microglia and astrocytes have 
phagocytotic activity, but most studies show that microglia are the primary 
phagocytotic cells in the brain. (Bechmann and Nitsch 1997; Ito et al. 2007; 
Koizumi et al. 2007; Neher et al. 2013). To determine whether the microglia are 
the primary phagocytic cells in our co-cultures, 5.5µm fluorescently labeled 
polystyrene beads were utilized. The cells were grown for 7-8 DIV and the beads 
were added for 1 hour. The cultures were then washed, fixed and stained with an 
antibody against Iba1 to label the microglia or an antibody against GFAP to label 
the astrocytes. As shown in the representative example in Figure 2, many beads 
(red) were observed within the Iba1 labeled microglia (green), but not the GFAP 
labeled astrocytes (green). Similar results were observed in four different culture 
preparations. These data demonstrate that the microglia in our cultures are indeed, 
the primary phagocytic cells.  
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Iron deposition within microglia & other cell types: 
 
 When heme is degraded by HO-1 into carbon monoxide and biliverdin, 
iron is released as a byproduct (Robinson et al., 2009; Dang et al., 2011). To 
observe the cell types in which the iron deposition occurs in response to different 
concentrations of hemin, 20 µM hemin or 100 µM hemin were added for 24 hrs, 
and then the cultures were stained for the presence of iron. Two representative 
preparations are shown in Figure 3, and similar results were observed in five 
different culture preparations. As shown, when the cultures are exposed to the 20 
µM hemin, which we propose corresponds to a mild-moderate injury, iron was 
localized primarily to the microglia. However, the addition of 100 µM hemin 
corresponding to a more severe injury, appears to overwhelm the microglia 
resulting in iron deposition in all the cell types throughout the cultures. These data 
demonstrate that microglia take up hemin from the environment, but there is a 
limit above which they cannot handle the hemin load.  Thus, the hemin is able to 
gain entry into microglia as well as astrocytes and neurons in the culture.   
HO-1 induction within microglia: 
 
 HO-1 is a protective enzyme that is induced in response to various injury 
models including models of hemorrhagic stroke (Robinson et al., 2009; Dang et 
al., 2011). When hemin enters the microglia, one would expect HO-1 mRNA and 
protein to be generated.  To test this, real-time RT-PCR assays were performd at 
three different time points after addition of 20 µM hemin or 100 µM hemin to the 
cultures. As shown, there is a significant induction of HO-1 in response to both 
concentrations of hemin, and these show the expected concentration and time 
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 dependence (Figure 4A). Specifically, the fold induction of HO-1 in response to 
20 µM hemin was significant at the 3 hr (~9-fold increase) and 12 hr (~17-fold 
increase) time points.  An even greater induction of HO-1 was observed in 
response to addition of 100 µM hemin, and was significant at all time points 
examined. To verify that HO-1 protein as well as mRNA is induced in a 
concentration-dependent manner, western immunoblotting was performed 12 hrs 
after addition of 20 µM hemin or 100 µM hemin. Figure 4E shows that there is 
little detectable HO-1 in control cultures, and that a concentration-dependent 
increase in HO-1 protein is observed after hemin challenge (actin was used as a 
loading control).  To determine if microglia are the primary source of HO-1 
protein induction, double-staining immunocytochemistry with antibodies against 
the microglia marker ED1 and antibodies against HO-1 was performed 12 hrs 
after addition of hemin (Figure 4C). Immunocytochemistry images show the 
induction of HO-1 (green) is primarily localized in the microglia (red).  
Neurotoxicity in response to hemin: 
 
 To measure the neurotoxicity in response to 20 µM hemin and 100 µM 
hemin, a LDH assay was done 24 hrs after the addition of the hemin. Insignificant 
death was observed in response to the 20 µM hemin challenge, compared to 
control cultures, but significant cell death was observed in response to the 100 
µM hemin (Figure 5A).  Using a caspase-3 death marker, it was determined that 
the cell death occurs in the granule neurons (green) and not in the microglia 
(Figure 5B-D).  Note that the caspase 3 experiments were performed by another 
member of the laboratory. 
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 Expression of inflammatory molecules: 
 When exposed to injury, such as an intracerebral hemorrhage, microglia 
can convert to a cytotoxic phenotype, which is associated with the expression of 
inflammatory molecules. To determine if there is a difference in the expression of 
inflammatory molecules in response to different concentrations of hemin, we 
assayed TNF-α, COX-2 and iNOS mRNA expression using real-time RT-PCR. 
TNF-α is an early cytokine in the injury cascade, and we observed a strong and 
significant induction of TNF-α in response to 100 µM at both the 1 and 3 hr time 
points, approaching 30-fold induction.  In contrast, a modest 7-fold induction of 
TNF-α was observed in response to the 20 µM hemin only at the 3 hr time point 
(Figure 6). Significant induction of COX-2 mRNA (approaching 65-fold), which 
is downstream of TNF-α in the injury cascade, is only observed in response to 
100 µM hemin and only at the 12 hr time point (Figure 7). Similarly, significant 
induction of iNOS mRNA (approaching 450-fold) is only observed in response to 
100 µM hemin, again only at the 12 hr time point (Figure 8).  Also shown is 
localization of iNOS to microglia in response to 100 µM hemin (Figure 8). 
Altogether, the cell death and RT-PCR data indicate that the low concentration of 
hemin does not trigger significant neuronal death and only induces a mild 
inflammatory response. Alternatively, the high concentration of hemin leads to 
significant neuronal death, and a robust inflammatory response.   
Phagocytosis of dead neurons by microglia:  
 
 To measure the ability of microglia to phagocytose dead CGNs, a live-
dead assay was performed in which cells were exposed to 20 µM hemin and 100 
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 µM hemin. As shown in Figures 9A-B, there were limited dead CGNs (red) in the 
control culture as well as the culture challenged with 20 µM hemin after 24 hrs. 
However, there was significant death in response to the 100 µM hemin (Figure 
9C). Despite the presence of microglia, the dead CGNs were not phagocytosed. 
For comparative purposes, results of a live-dead assay performed in our lab using 
250 µM kainate to mimic an ischemic injury are presented. In this injury model, 
there were very few dead CGNs after 24 hrs indicating that phagocytosis had been 
completed by this time (Figure 9E). We can be sure there was CGN death after 24 
hrs by looking at the histogram presented in Figure 9F in which the addition of 
AraC (to decrease glial growth) and kainate is shown to increase cell death. To 
observe the phagocytic activity, cultures were fixed 3 hrs after kainate exposure, 
and numerous dead neurons (red) were visible within the ED1 labeled phagocytic 
microglia (Figure 9G). This discrepancy in the activity of the microglia in 
response to hemin verses the kainate indicates that the microglia are able to engulf 
dead neurons but the addition of high concentrations of hemin compromises their 
phagocytic function.  
Defined medium and protection by albumin 
The presence of serum proteins, such as albumin and hemopexin, can bind blood 
products such as hemin, and slowly release them to be processed by microglia 
after a brain bleed (Belayev et al., 2005).  We examined the protective effect of 
serum albumin against hemin-induced neuronal death in our co-cultures. To test 
this, we used co-cultures grown in a chemically defined medium that does not 
include fetal bovine serum in conjunction with hemin addition plus or minus co-
 13 
 addition of albumin, followed 24 hrs later by a live-dead assay.  As exemplified in 
Figure 10 (and observed in 3 separate culture preparations), significant cell death 
was observed in response to both 20 µM hemin and 100 µM hemin 24 hours after 
its addition, with essentially total neuronal death in response to the higher 
concentration.  The significant neuronal death observed after addition of 20 µM 
hemin is not unexpected since the growth medium does not contain serum 
proteins, unlike the data shown in Figure 9 (top panels). Co-addition of an equal 
concentration of albumin (20 µM and 100 µM) to the cultures proved to be 
protective, and significantly decreased the amount of cell death in response to 
both concentrations of hemin (Figure 10).   
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 Discussion  
 
 Although hemorrhagic strokes are less common than ischemic strokes, 
they have a significantly higher morbidity and mortality (Taylor and Sensing, 
2013). Currently, we lack effective treatments for individuals who have 
intracerebral hemorrhages. Thus, there is a critical need to understand more about 
the genesis of the injury process, and also to develop strategies to ameliorate the 
extent of tissue damage. Scientific evidence shows that microglia impact, and are 
impacted by, astrocytes and neurons (Sudo et al. 1998; Rosenstiel et al. 2001; 
Kettenmann et al. 2011; Ousman and Kubes 2012). Microglia in different brain 
regions also demonstrate functional and morphological heterogeneity (Lawson et 
al. 1990; Elkabes et al. 1996; Ren et al. 1999; de Haas et al. 2008). To accurately 
explore microglia functional effector states in vitro, we co-culture microglia, 
astrocytes and neurons using cerebellar cortex as our tissue source. Thus, all cells 
in the co-cultures come from the same brain region. To promote the growth of the 
glial cells in our co-cultures, we omit the mitotic inhibitor, AraC, which is 
typically included in the growth medium to enrich CGNs (Thangnipon et al. 1983; 
Kingsbury et al. 1985). As exemplified in Figure 1, we estimate that at 7-8 DIV 
microglia and astrocytes represent ~11% and ~10%, respectively, of the cell 
population, which is similar to what would be found in vivo. In summary, we 
observe that microglia and astrocytes proliferate when AraC is not added to the 
medium so that neuron-glia co-cultures from the same brain region can be 
examined in our injury model. 
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  When placed in primary culture, microglia assume an amoeboid shape and 
they express ED1 indicating that are not true “resting” microglia, which 
predominate in brain tissue and exhibit a highly ramified morphology, compact 
cell soma, and no expression of ED1 (Damoiseaux et al. 1994; Ito et al. 2001). 
The basal state of these microglia in our co-cultures is not characterized by 
expression of inflammatory molecules (Figures 6-8), and they are effective 
phagocytes when challenged with a cargo such as latex beads (Figure 2). 
Similarly, when challenged with the lower concentration of hemin, the microglia 
effectively contain the hemin load, as shown by iron deposition localized to 
microglia only (Figure 3), only a modest induction of one of the inflammatory 
markers at a single time point (TNF-α at 3 hours, Figure 6), and no significant 
neuronal death (Figure 5).  Importantly, there was significant induction of HO-1 
protein and mRNA in response to 20 µM hemin, demonstrating that the amount of 
hemin used to challenge the cultures was sufficient to induce a microglia 
response.  When challenged with the higher concentration of hemin, the microglia 
appear to convert to an inflammatory (Figure 6-8), possibly cytotoxic phenotype 
that is unable to phagocytose dead neurons (Figure 5, Figure 9/upper panels). 
Consistent with this, iron deposition is observed throughout the culture (Figure 3). 
Not unexpectedly, there was even greater induction of HO-1 protein and mRNA 
in response to 100 µM hemin (Figure 4).  Challenge of co-cultures with a 
different toxic agent, kainate, was used to demonstrate that microglia in the co-
cultures are able to effectively phagocytose essentially all of the dead neurons 
within a 24 hour time period (Figure 9, lower panels). Possibly, the phagocytic 
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 function of microglia is compromised when they are actively catabolizing hemin. 
For example, Mairuae and associates (2011) reported that iron accumulation 
interfered with the ability of microglia to phagocytose zymosan.  
 For effective treatment of humans with hemorrhagic stroke, it is crucial to 
distinguish between microglial functional effector states.  In cases of mild-to-
moderate injury, for example our 20 µM hemin condition, microglia appear able 
to effectively remove and catabolize the hemin without mounting a robust 
inflammatory response, and there is no observable cell death. Thus, it would be 
counter-productive to inhibit these important protective functions of microglia if 
such a situation was observed in the patient. In contrast, cases of severe or 
sustained injury, for example our 100 µM hemin condition, microglia appear 
unable to effectively remove and catabolize the hemin. Consistent with this, iron 
is deposited in all cell types in the culture (Figure 3). Moreover, they mount a 
robust inflammatory response, and there is profound cell death. These data are in 
good agreement with studies using other model systems, where significant 
induction of TNF-α, COX-2 and iNOS in microglia exacerbate neuronal death 
(Bal-Price and Brown, 2001; von Bernhardi et al. 2007; Cho et al. 2008; Blaylock 
2013; Xing et al. 2015). Thus, it maybe useful to inhibit this potentially cytotoxic 
state that microglia have assumed, but only if one can preserve the protective 
functions while so doing. It might prove difficult to establish the appropriate 
conditions to achieve this goal. Another possible strategy would be to promote 
microglial proliferation, so as to avoid their being overwhelmed by the hemin 
load. Finally, our studies using cultures grown in chemically defined medium 
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 indicate that administration of agents that bind toxic blood products, and slowly 
release them for catabolism by microglia, may attenuate neuronal damage. Future 
studies using our model will explore the potential value of such strategies. 
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 Appendix 1 
 
 
Table 1: Primers used for PCR 
 
Name Sense Antisense 
TNFα 5’-GTAGCCCACGTCGTAGCAAA-3’ 5’-CCCTTCTCCAGCTGGGAGAC-3’ 
COX2 5’-CCATGTCAAAACCCGTGGTGAATG-3’ 5’-ATGGGAGTTGGGCAGTCATCAG-3’ 
iNOS 5’-GCAGAATGTGACCATCATGG-3’ 5’-ACAACCTTGGTGTTGAAGGC-3’ 
18S 5’-CGCCGCTAGAGGTGAAATTC-3’ 5’-TTGGCAAATGCTTTCGCTC-3’ 
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 Appendix 2 
 
Figure 1: The three primary cell types in our co-cultures. Microglia labeled green 
with an Iba1 marker, astrocytes labeled red with a GFAP marker, and clusters of 
neuronal nuclei labeled blue with Hoechst.  
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 Appendix 3 
 
 
 
Figure 2: Phagocytic activity of microglia demonstrated by the presence of 5.5 
µm beads within the (A) Iba1 labeled microglia and the absence of beads within 
the (B) GFAP labeled astrocytes.  
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 Appendix 4 
 
 
 
Figure 3: Deposition of iron within microglia and other cell types observed in 
cell Prep A and cell Prep B after the addition of 20 µM hemin and 100 µM hemin.  
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 Appendix 5 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4: (A) Induction of HO-1 mRNA in response to 20 µM hemin and 100 
µM hemin, as assessed by real time RT-PCR assays. (B-D) Immunocytochemistry 
images taken 12 hours after exposure to 20 µM hemin and 100 µM hemin 
showing the localization of green-labeled HO-1 protein within the red-labeled 
ED1 protein that is a microglia marker.  E. Western immunoblot of hemin protein 
expression 12 hrs after addition of control, 20 µM hemin, or 100 µM hemin. 
Actin loading controls are shown in the lower panels. 
n=5 A 
B           Control C          Hemin 20 D          Hemin 100 
E 
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 Appendix 6 
 
 
 
 
 
Figure 5: (A) Neurotoxicity measured in response to 20 µM hemin and 100 µM 
hemin using a LDH assay, performed 24 hours following hemin addition. (B-D) 
Cell death observed in granule neurons labeled green using a caspase-3 death 
marker (green label).  
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Appendix 7 
 
 
 
Figure 6: TNFα mRNA induction in response to 20 µM hemin and 100 µM 
hemin, as assessed by real-time RT-PCR assays. 
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Appendix 8 
 
 
 
Figure 7: COX-2 mRNA induction in response to 20 µM hemin and 100 µM 
hemin, as assessed by real-time RT-PCR assays. 
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Appendix 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: A. iNOS mRNA induction in response to 20 µM hemin and 100 µM 
hemin, as assessed by real-time RT-PCR assay. B. Immunocytochemical staining 
with ED1 antibodies to label microglia (red) co-localize with iNOS expression 
(green) after addition of 100 µM hemin. 
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Appendix 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: (A-C) Challenge with 20 µM hemin results in little death while 
exposure to 100 µM hemin results in extensive CGN death. Despite the presence 
of microglia, the dead CGNs (red) were not engulfed after 24 hrs. (D-E) When 
challenged with 250 µM kainate, to mimic an ischemic injury, there is an absence 
of dead (red) CGNs after 24 hrs indicating that phagocytosis is complete by this 
time. (F) The histogram in panel F shows that there was significant CGN death 
after 24 hrs (Re: -AraC conditions showing ~66% cell death after kainite 
exposure). (G) To observe the phagocytic activity directly, the cultures were fixed 
3 hrs after exposure to kainate. This image reveals the presence of numerous dead 
A 
A            Control B         20µM Hemin C      100µM Hemin 
G            3 hour  
D          Control F E          Kainate 250µM 
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 neurons (red) within Iba1 labeled phagocytic microglia (green). Note that the 
magnification in this image is ~ 2x greater than those in images A-E.  
Appendix 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Co-cultures were grown in a chemically defined medium that does not 
include fetal bovine serum.  Vehicle control (A) or hemin was added in the 
absence (B, C) or presence (D, E) of an equal amount of albumin (20 µM or 100 
µM), and live-dead assays were done 24 hours later. Living cells are shown in 
green; dead cells are shown in red. 
A            Define Control 
B            Define Hemin 20 C            Define Hemin 100 
D    Define Hemin 20 + albumin E  Define Hemin 100 + albumin 
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